Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BioTech is Scopus-indexed (Q2, CiteScore 5.6), WoS ESCI, DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2673-6284Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biomedical Engineering | 136 / 342 | 60th | Q2 |
| Biotechnology | 135 / 325 | 58th | Q2 |
| Applied Microbiology and Biotechnology | 57 / 134 | 57th | Q2 |
| Biochemistry | 191 / 448 | 57th | Q2 |
| Bioengineering | 86 / 168 | 49th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 5.6.
BioTech is Q2 in Biomedical Engineering (rank 136 of 342), Q2 in Biotechnology (rank 135 of 325) and Q2 in Applied Microbiology and Biotechnology (rank 57 of 134), by CiteScore 2025. It is ranked in 5 subject areas in all.
BioTech is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.6, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.710, quartile Q2, with an H-index of 30.
The publisher lists an article processing charge of about US$1,930 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
BioTech is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2673-6284.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
BioTech has an h-index of 29 and a 2-year mean of 4.04 citations per paper (OpenAlex). Its Scopus CiteScore is 5.6, quartile Q2. On 2-year citations it ranks #111 of 322 Scopus journals in Biomedical Engineering.
BioTech published 100 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from China (10.3%), United States (10.1%) and Mexico (9.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.